<DOC>
	<DOCNO>NCT01532479</DOCNO>
	<brief_summary>The purpose study determine Hyperbaric Oxygen ( HBO ) therapy improve salivary gland function previously head-and-neck irradiated patient . The following evaluated : salivary a-amylase , IGF-1 , Thrombospondin-1 , VEGF-A concentration , rest stimulate salivary flow rate pH , salivary buffering capacity . Demographic data , past medical/surgical history , social history habit , risk factor , medication list , nutritional status , stage location tumor treat , dose/duration radiation , time elapse since radiation treatment review record . Subjects complete quality life questionnaire , describe ( presence/absence ) dry mouth symptom prior HBO therapy , provide current A1c level , submit finger stick . The follow group evaluate : 1 . Head-and-neck irradiated subject ORN ( indicate HBO therapy ) 2 . Subjects condition indicate HBO therapy ( positive control ) , 3 . Head-and-neck irradiated subject without ORN ( negative control ) . Subjects include 78 male female , 18 year old . In total , participation last 22 week .</brief_summary>
	<brief_title>Saliva , Hyperbaric Oxygen Therapy , &amp; Gland Function : A Prospective Study</brief_title>
	<detailed_description>This prospective study human model examine treatment patient sustain damage salivary gland follow head neck radiation , subsequent xerostomia , currently indicate hyperbaric oxygen therapy treatment osteoradionecrosis . Salivary flow rate , pH buffering capacity hyperbaric oxygen treatment collect use GC America ( Alsip , Illinois ) Saliva-Check BUFFER Kit result record . The 6 test take 10 minute complete per patient . According GC America , test simple , demonstrate salivary dysfunction , help identify factor affect salivary dysfunction , assist diagnosis xerostomia . Salivary test data collection occur 8 independent visit course hyperbaric oxygen treatment follow-up . Stimulated saliva sample use measure proteins involve salivary gland revascularization repair . Saliva sample store less equal -20C 1 year . Measurements salivary VEGF-A , IGF-1 , Thrombospondin-1 quantify use R &amp; D Systems ( Minneapolis , MN ) ELISA kit result record . Salivary Alpha-Amylase measure use Rocky Mountain Diagnostics , Inc ( Colorado Springs , CO ) Alpha-Amylase Saliva kit . Protein analysis do stimulate saliva sample collect 4 independent visit : first week , fourth week , eighth week , sixteenth week . The medical , surgical , health history participant review . Each participant complete EORTC quality life core questionnaire ( QLQ - C30 v3.0 ) , include head neck cancer module , start completion trial . A blood sample participant drawn , analyze A1c level albumin level . During first , fourth , eighth , sixteenth week , follow Saliva-Check BUFFER Kit test do HBO therapy , additional saliva collect ensure minimum 2 mL saliva store less equal -20 oC protein analysis . After salivary testing , patient enter hyperbaric oxygen chamber locate Loma Linda University Medical Center . The patient gradually elevate therapeutic oxygen level 8-12 minute period . At time , 100 % oxygen administer 2.0 ATA 2.5 ATA , discretion treat physician , 90 minute . A 10-minute air-break give first 45 minute patient 2.5 ATA protocol . At conclusion oxygen treatment , oxygen pressure level gradually decrease 8-12 minute return depth 1 ATA . After exit hyperbaric oxygen chamber , salivary testing perform patient . Collected data compare two independent control group . The Positive Control Group include 26 individual fit inclusion exclusion criterion : participant hyperbaric oxygen treatment indicate , radiation therapy head neck cancer . The Negative Control Group include first 26 individual fit inclusion exclusion criterion : participant previously head neck radiation therapy , hyperbaric oxygen treatment indicate . Salivary data Positive Control Group collect way parallel data collect Treatment Group . Salivary data collect way Negative Control Group follow modification : salivary flow rate test perform visit salivary testing space basis time day contrast number hyperbaric oxygen treatment session .</detailed_description>
	<mesh_term>Xerostomia</mesh_term>
	<mesh_term>Osteoradionecrosis</mesh_term>
	<criteria>Patient age : 18+ . Patient must give informed consent . Treatment Group Patient complete head neck irradiation treatment . Hyperbaric oxygen therapy indicate patient accept say treatment . Patient must able complete hyperbaric oxygen course treatment . Positive Control Group Hyperbaric oxygen therapy indicate patient accept say treatment . Patient must able complete hyperbaric oxygen course treatment . Negative Control Group Patient complete head neck irradiation treatment . Hyperbaric oxygen therapy use . Currently use anticholinergic agent , eg : Scopolamine patch , Atropine , Ipratropium , Spiriva .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Osteoradionecrosis</keyword>
	<keyword>Xerostomia</keyword>
</DOC>